• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

3.910 +0.070 (+1.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,404,710
Open 3.760
Bid (Size) 3.780 (2)
Ask (Size) 4.100 (20)
Prev. Close 3.840
Today's Range 3.760 - 3.930
52wk Range 3.760 - 29.30
Shares Outstanding 92,200,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Cash-Burning Stock to Target This Week and 2 We Brush Off
August 01, 2025
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
Myriad Genetics Announces New $200 Million Credit Facility
July 31, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire

Performance

YTD
-71.0%
-71.0%
1 Month
-30.2%
-30.2%
3 Month
-49.2%
-49.2%
6 Month
-69.4%
-69.4%
1 Year
-85.3%
-85.3%

More News

Read More
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
July 29, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
Why Myriad Genetics (MYGN) Shares Are Falling Today
July 29, 2025
Via StockStory
Topics Artificial Intelligence Lawsuit
3 Volatile Stocks with Warning Signs
July 21, 2025
Via StockStory
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
July 18, 2025
Via StockStory
Topics Lawsuit World Trade
3 of Wall Street’s Favorite Stocks in Hot Water
July 17, 2025
Via StockStory
Myriad Genetics Earns 2025 Great Place To Work Certification™
July 15, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
July 11, 2025
Via StockStory
Topics ETFs Stocks World Trade
3 High-Flying Stocks Facing Headwinds
June 23, 2025
Via StockStory
Topics Malware
3 Stocks Under $10 in the Doghouse
June 05, 2025
Via StockStory
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
June 03, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
June 02, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
3 Cash-Burning Stocks Facing Headwinds
May 30, 2025
Via StockStory
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
May 27, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
May 26, 2025
Via StockStory
Topics Artificial Intelligence
3 Small-Cap Stocks with Questionable Fundamentals
May 22, 2025
Via StockStory
This UnitedHealth Group Analyst Turns Bearish; Here Are Top 3 Downgrades For Wednesday
May 21, 2025
Via Benzinga
CI&T, Novavax, Paramount Group And Other Big Stocks Moving Higher On Monday
May 19, 2025
Via Benzinga
MYGN Q1 Earnings Call: Guidance Cut Amid GeneSight Challenges and Slow Hereditary Cancer Ramp
May 19, 2025
Via StockStory
Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
May 14, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks in Dangerous Territory
May 12, 2025
Via StockStory
Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
May 08, 2025
From Glancy Prongay & Murray LLP
Via Business Wire
Myriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 08, 2025
From Law Offices of Howard G. Smith
Via Business Wire
Myriad Genetics Shares Tank 41% On Analyst Downgrades, Weaker Guidance: Yet Retail Investors Remain Bullish
May 07, 2025
Via Stocktwits

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 3.910
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 360.50M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 361M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap